Spots Global Cancer Trial Database for Flu Vaccine Responses in the Setting of Melanoma Treatment

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Flu Vaccine Responses in the Setting of Melanoma Treatment

Official Title: Influenza Vaccine Responses in the Setting of Melanoma Treatment

Study ID: NCT03315975

Conditions

Viral Vaccines

Interventions

Inactivated influenza vaccine

Study Description

Brief Summary: Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. We are conducting a prospective unblinded study of influenza vaccine recipients.

Detailed Description: Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. In particular, immune responses following influenza vaccination have not been studied in the setting of advanced melanoma and in the context of various anti-tumor treatments. In this study, we will look at the immune response of subjects receiving vaccination.